![GettyImages-900882412-600x375](https://medphanut.com/wp-content/uploads/2024/05/GettyImages-900882412-600x375.jpg)
In part 2 of our Q&A, Okamura addresses the need for biopharma companies to leverage digital technologies in disease management.
The post Astellas Pharma CEO Q&a (Part 2): We Have To Have Alternatives for Prescription Medicine Business appeared first on MedCity News.